During the last earnings call, Dane Hallberg mentioned that, for any product launch, you always launch it first with the payers. I am assuming that "payers" means the insurance companies. I got the feeling that he was implying that Braeburn's product launch failed because they did not get the buy-in from the insurance companies, which in turn prevented physicians from prescribing Probuphine. I think Dane understands the business side things and I have no doubt that Probuphine will succeed in the long run. There will come a day when either Probuphine or some other Proneura delivered formulation will become the standard in US prison systems as well as other settings. To me the real question is time. How long will the ramp up take and will there be additional dilutions along the road. Trust me, dilutions suck shit.
And then there is Ropinirole. Now here is a product with serious possibilities! Ropinirole is intended to treat people with Parkinsons. This is a population that is that is insured to a hilt! Old people. Not only that, but the population with Parkinsons is growing in the United States, Europe and....and...China! For those that have not kept up on demographics, China has 1.4 billion people. That is roughly just over 4 times the population of the United States. I have to believe that Sunil & crew are furiously looking for a partner that can help bring Ropinirole to market. In my view, a large European Pharmaceutical would be perfect. Maybe that is what Federico Seghi Recli is working on and why he bought a boatload of shares.
In closing I will mention that I own TTNP shares and have done so for some years. Trust me, this is not a pump and dump. I get exasperated from time to time but then I run the numbers and they keep telling me the same thing. There is no way this thing fails. Not in the long run. Last year 875 thousand people received Suboxone. If Titan captures 1% of that market, that translates to roughly $35 million in sales. Folks, if you are long, you have a winner here. However, time is our enemy. This needs to ramp up a little (lot actually) quicker. Best of luck to all.
